Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-07 Purchase |
2025-02-11 5:58 pm |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
240,000 | $5 | $1,200,000 | 2,884,121 (Indirect) |
View |
| 2024-12-24 Purchase |
2024-12-26 08:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
4,500 | $4.65 | $20,925 | 3,270,924 (Direct) |
View |
| 2024-12-12 Purchase(A) |
2024-12-16 5:37 pm |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
49,121 | $4.6608 | $228,941 | 2,644,121 (Direct) |
View |
| 2024-12-13 Purchase |
2024-12-16 08:00 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
17,000 | $4.7 | $79,900 | 2,612,000 (Direct) |
View |
| 2024-11-19 Purchase |
2024-11-20 08:30 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
2,000 | $4.99 | $9,980 | 1,506,319 (Direct) |
View |
| 2024-11-15 Purchase |
2024-11-18 08:30 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
20,000 | $4.92 | $98,400 | 3,266,424 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 3:59 pm |
Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance |
2,755 | $8.159 | $22,478 | 87,918 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 09:16 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,940 | $6.74 | $13,076 | 3,246,424 (Direct) |
View |
| 2024-05-10 Purchase |
2024-05-13 08:51 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
2,000 | $6.4 | $12,800 | 3,244,484 (Direct) |
View |
| 2024-05-10 Purchase |
2024-05-13 08:49 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
500 | $6.29 | $3,145 | 1,504,319 (Direct) |
View |
| 2024-05-10 Purchase |
2024-05-13 08:47 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
1,113 | $6.32 | $7,034 | 1,493,068 (Direct) |
View |
| 2024-03-18 Purchase |
2024-03-19 08:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
5,000 | $10.29 | $51,450 | 3,242,484 (Direct) |
View |
| 2023-10-10 Purchase |
2023-10-12 4:05 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
640 | $11.08 | $7,091 | 3,237,484 (Direct) |
View |
| 2023-10-06 Purchase |
2023-10-10 08:30 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,080 | $11.21 | $12,105 | 3,236,844 (Direct) |
View |
| 2023-10-04 Purchase |
2023-10-06 08:37 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
3,220 | $11.01 | $35,455 | 3,235,764 (Direct) |
View |
| 2023-08-15 Purchase |
2023-08-16 4:05 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
350 | $14.61 | $5,112 | 3,232,544 (Direct) |
View |
| 2023-08-08 Purchase |
2023-08-11 6:07 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
300 | $14.73 | $4,418 | 3,232,194 (Direct) |
View |
| 2023-07-31 Purchase |
2023-08-01 08:00 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
860 | $13.88 | $11,937 | 2,595,000 (Direct) |
View |
| 2023-07-28 Purchase |
2023-07-31 08:00 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
2,584 | $13.91 | $35,943 | 2,594,140 (Direct) |
View |
| 2023-07-27 Purchase |
2023-07-28 08:00 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
1,556 | $13.98 | $21,753 | 2,591,556 (Direct) |
View |
| 2023-07-26 Purchase |
2023-07-27 06:52 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
10,000 | $13.97 | $139,700 | 2,590,000 (Direct) |
View |
| 2023-07-20 Purchase |
2023-07-24 4:45 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
335 | $14.92 | $4,998 | 3,231,894 (Direct) |
View |
| 2023-07-20 Purchase |
2023-07-24 4:45 pm |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
8,238 | $14.47 | $119,224 | 2,580,000 (Direct) |
View |
| 2023-07-19 Purchase |
2023-07-20 06:30 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
8,000 | $14.84 | $118,720 | 2,571,762 (Direct) |
View |
| 2023-07-19 Purchase |
2023-07-20 06:30 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
200 | $14.33 | $2,866 | 3,231,559 (Direct) |
View |
| 2023-07-18 Purchase |
2023-07-19 08:06 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
9,149 | $14.84 | $135,771 | 2,563,762 (Direct) |
View |
| 2023-07-07 Purchase |
2023-07-18 08:34 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
260 | $15.52 | $4,035 | 3,231,359 (Direct) |
View |
| 2023-07-12 Purchase |
2023-07-13 08:30 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
3,285 | $15.09 | $49,571 | 2,554,613 (Direct) |
View |
| 2023-07-11 Purchase |
2023-07-12 08:30 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
10,000 | $15.36 | $153,600 | 2,551,328 (Direct) |
View |
| 2023-07-07 Purchase |
2023-07-10 08:00 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
8,948 | $15.19 | $135,920 | 2,541,328 (Direct) |
View |
| 2023-07-06 Purchase |
2023-07-07 08:04 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
3,179 | $15.01 | $47,717 | 2,532,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 6:13 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
150,000 | $0 | 1,643,068 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:12 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
150,000 | $0 | 1,656,319 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:10 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance |
51,000 | $0 | 138,918 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:09 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
250,000 | $0 | 3,520,924 (Direct) |
View |
| 2023-01-03 Option Award |
2024-11-08 3:59 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Carson Michael J. Vice President, Finance |
63,373 | $0 | 87,918 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 4:22 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
30,000 | $0 | 83,760 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 4:22 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
30,000 | $0 | 103,140 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 4:21 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director |
30,000 | $0 | 57,828 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:31 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
130,000 | $0 | 1,503,819 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:30 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
130,000 | $0 | 1,491,955 (Direct) |
View |